Provided by Tiger Trade Technology Pte. Ltd.

Omeros

18.79
-0.0020-0.01%
Volume:185.68K
Turnover:3.47M
Market Cap:1.36B
PE:11.96
High:18.87
Open:18.66
Low:18.48
Close:18.79
52wk High:19.65
52wk Low:3.94
Shares:72.38M
Float Shares:67.73M
Volume Ratio:1.16
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.57
EPS(LYR):-0.0527
ROE:-576.33%
ROA:-18.68%
PB:-26.48
PE(LYR):-356.19

Loading ...

Omeros Director Arnold C. Hanish Sells USD 189,713 of Common Shares

Reuters
·
Aug 29

Omeros VP Finance, CAO David J. Borges Reports Disposal of Common Shares Worth $206,935.60

Reuters
·
Aug 26

Insider Shake-Up at Omeros as Key Director Sells Off a Chunk of Shares

TIPRANKS
·
Aug 22

Omeros Director Thomas J. Cable Disposes of 15,000 Common Shares for $276,772.50

Reuters
·
Aug 22

Omeros Director Joseph L. Schocken Files Initial Beneficial Ownership Statement

Reuters
·
Aug 19

Why Omeros (OMER) Is Up 27.5% After Swinging To Profitability And Completing Share Buyback

Simply Wall St.
·
Aug 18

Omeros VP Finance, CAO David J. Borges Sells 5,000 Shares Worth $84,750

Reuters
·
Aug 18

Scienture Q2 Revenue Surges on Rezenopy Launch

Reuters
·
Aug 14

Omeros’ $100 Million Buyback Plan: How Discretionary Repurchases Could Distort Share Price and Heighten Volatility

TIPRANKS
·
Aug 14

Omeros Appoints Veteran Investor Joseph Schocken to Board

TIPRANKS
·
Aug 14

Omeros Appoints Tranceka Capital Founder Joseph Schocken to Board

Reuters
·
Aug 14

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

ARS Pharmaceuticals Q2 Neffy Revenue Rises as Epinephrine Market Share Doubles

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Biofrontera Q2 Revenue Rises on Higher Volume, Pricing

Reuters
·
Aug 13

CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance

Reuters
·
Aug 13

Karyopharm Q2 Revenue Falls as License Revenue Drops; Expects Funds to Last into September

Reuters
·
Aug 13

Pelthos Therapeutics Q2 Revenue Rises on Zelsuvmi Adoption

Reuters
·
Aug 13

Omeros Maintained at Buy as Strong YARTEMLEA Launch and Reduced C5 Competition Support Unchanged $33 Price Target

TIPRANKS
·
Aug 13

Omeros Jumps on Surprise Quarterly Profit

Reuters
·
Aug 13